Bladder Cancer – Symptoms, Causes, Diagnosis, Stages & Treatment (2026)

There is one symptom of bladder cancer that doctors say is almost impossible to ignore — and yet millions of people ignore it every single year. It is blood in the urine.

You notice it once. It is alarming. Then it disappears — and because it has gone away, you tell yourself it was probably nothing. A urinary infection. Something you ate. It will sort itself out.

And sometimes weeks or months later, it comes back. By then, the cancer has had more time to grow.

This is the most dangerous thing about bladder cancer — it gives you early warnings, and those warnings are easy to dismiss. According to the World Health Organization, bladder cancer is one of the most common cancers in India, responsible for 3% of all cancer cases. It often goes undetected in its early stages because its symptoms mimic less serious conditions like urinary tract infections.

But here is the most important thing you need to know: when bladder cancer is diagnosed and treated in its early stages, the chances of successful treatment and long-term survival are significantly higher. Early-stage bladder cancer has a survival rate of over 90%. That number drops dramatically with every stage of progression.

This complete guide covers everything about bladder cancer — what it is, the types, symptoms to watch for, causes and risk factors, how it is diagnosed, the stages, every available treatment option, and how Doctor Visit Bangalore helps patients access the best bladder cancer care in India.

What Is Bladder Cancer?

Your bladder is a hollow, balloon-shaped organ in your lower abdomen. Its job is to store urine produced by the kidneys until your body is ready to release it. The inside of the bladder is lined with cells called urothelial cells — and it is in these cells that most bladder cancers begin.

Bladder cancer occurs when abnormal cells develop in the lining of the bladder and grow uncontrollably. Over time, this cancer can invade deeper layers of the bladder wall and spread to nearby lymph nodes or distant organs.

Think of the bladder wall as having several layers — like the layers of an onion. The innermost layer is the urothelium. Behind it is a thin layer of connective tissue, then a layer of muscle, and finally the fatty tissue surrounding the bladder. When cancer starts in the urothelium and stays there, it is called non-muscle-invasive bladder cancer — and it is highly treatable. When it grows through those inner layers into the muscle wall, it becomes muscle-invasive — much more serious and harder to treat.

This is why the stage at which bladder cancer is detected makes such an enormous difference to treatment options and outcomes.

Types of Bladder Cancer

Not all bladder cancers are the same. Understanding the type helps your doctor plan the most effective treatment.

1. Urothelial Carcinoma (Transitional Cell Carcinoma) — Most Common

This is the most common type, originating in the urothelial cells lining the inside of the bladder. It can also affect the kidneys, ureters, and urethra. Urothelial carcinoma accounts for approximately 90% of all bladder cancer cases in India and worldwide. It can be non-invasive (confined to the inner lining) or invasive (penetrating into deeper muscle layers).

2. Squamous Cell Carcinoma

This type develops from squamous cells — flat cells that can form in the bladder in response to long-term irritation or inflammation. It is linked to chronic irritation or infections such as recurrent UTIs or long-term catheter use. It is more common in regions where schistosomiasis — a parasitic infection — is prevalent. Squamous cell carcinoma accounts for about 5% of bladder cancers.

3. Adenocarcinoma

A rare type of bladder cancer that develops from glandular cells. It accounts for only 1 to 2% of bladder cancers but tends to be more aggressive than urothelial carcinoma. Adenocarcinoma is often found in the dome of the bladder.

4. Urachal Cancer

A rare and aggressive type of bladder cancer that originates in the urachus — a fibrous remnant of the umbilical cord. It is usually an adenocarcinoma and frequently occurs in an advanced stage.

5. Sarcoma of the Bladder

A very rare cancer arising from the muscle or connective tissue of the bladder. Bladder sarcomas are extremely uncommon and require specialised treatment at major cancer centres.

6. Small Cell Carcinoma of the Bladder

The rarest and most aggressive type. It begins in nerve-like cells called neuroendocrine cells and tends to grow and spread very quickly. Treatment is similar to small cell lung cancer and usually involves chemotherapy.

Non-Muscle-Invasive vs Muscle-Invasive Bladder Cancer

Beyond the cell type, bladder cancer is also classified by how deeply it has grown into the bladder wall — and this distinction fundamentally changes the treatment approach:

Non-Muscle-Invasive Bladder Cancer (NMIBC): The cancer is confined to the inner lining of the bladder and has not grown into the muscle layer. This is the most common presentation — about 75% of bladder cancers are NMIBC at diagnosis. It is highly treatable, usually without removing the bladder.

Muscle-Invasive Bladder Cancer (MIBC): The cancer has grown through the inner lining into the muscle wall of the bladder. This is more serious and may require removal of part or all of the bladder. About 25% of bladder cancers are muscle-invasive at diagnosis.

Metastatic Bladder Cancer: The cancer has spread beyond the bladder to distant lymph nodes or other organs — most commonly the lungs, liver, and bones.

Symptoms of Bladder Cancer — What to Watch For

Bladder cancer can cause a wide range of symptoms, some of which are easily overlooked. Knowing the early warning symptoms can help to detect the cancer in its early stages.

Most Common Symptom — Blood in Urine (Haematuria)

The most common sign is blood in urine. It may be visible or microscopic, but it should never be dismissed. Visible blood in the urine — called gross haematuria — can turn the urine pink, red, or the colour of dark tea. In some cases, blood is only detectable through a urine test — called microscopic haematuria.

One of the most dangerous misconceptions about haematuria is that because it comes and goes, it is not serious. Blood in the urine can appear once, disappear completely for weeks or months, and then return. This intermittent nature does not mean it is harmless — in fact, it is one of the hallmark patterns of bladder cancer.

Any blood in urine — even once — should be investigated by a doctor immediately.

Other Symptoms to Watch For

Frequent urination: Patients might feel like they need to urinate right away, even when the bladder is not full.

Painful urination (dysuria): A burning or stinging sensation when passing urine — similar to a urinary tract infection.

Urgency: A sudden, strong urge to urinate that is difficult to control.

Back pain: Unexplained lower back pain, particularly on one side, may indicate advanced stages of bladder cancer.

Difficulty urinating: In some cases, patients may experience weak urine flow or find it difficult to pass urine.

Urinating at night: Bladder cancer patients might have to get up to urinate many times during the night.

Weight loss: Patients may lose weight unintentionally. Fatigue: Patients may feel tired or weak. Swelling in the feet: Patients may experience swelling in the feet. These symptoms are more common in advanced bladder cancer.

Symptoms in Women — Easy to Miss

In women, bladder cancer symptoms are frequently misattributed to urinary tract infections, menstrual irregularities, or menopause-related changes. Women are often treated for UTIs multiple times before a bladder cancer diagnosis is considered — which leads to dangerous delays. If you are a woman experiencing recurrent UTIs or persistent urinary symptoms that do not fully resolve with treatment, insist on a urine cytology test.

Important Note

Having any of these symptoms does not mean you have bladder cancer. These symptoms can be caused by many benign conditions — UTIs, kidney stones, benign prostatic hyperplasia in men, and others. But they should always be investigated promptly because when bladder cancer is the cause, early detection dramatically improves outcomes.

Causes and Risk Factors of Bladder Cancer

The exact cause of bladder cancer in any individual is rarely identifiable. What we know is that certain factors significantly increase the risk of developing it.

1. Smoking — The Biggest Risk Factor

Smoking is the biggest cause. Chemicals in tobacco are filtered by the kidneys and end up in the bladder, irritating its lining for years. Smokers are 2 to 3 times more likely to develop bladder cancer than non-smokers. The risk increases with the number of cigarettes smoked and the duration of smoking. Stopping smoking reduces the risk — but it takes many years to return to the level of a non-smoker.

2. Chemical and Occupational Exposure

Certain industrial exposures, like dyes and rubber, also add risk. Workers in industries involving aromatic amines — including textile dyes, rubber manufacturing, leather processing, paint manufacturing, and printing — have significantly higher rates of bladder cancer. The carcinogens are absorbed through the skin or inhaled, enter the bloodstream, are filtered by the kidneys, and collect in the urine — repeatedly exposing the bladder lining.

3. Age

Age plays a role — most patients are older adults. The risk of bladder cancer increases significantly with age. The majority of patients are over 55 at diagnosis, with the average age at diagnosis being around 73. However, bladder cancer can occur at any age.

4. Gender — Men More Affected Than Women

Bladder cancer is prevalent in India and affects men more than women. Men are approximately 3 to 4 times more likely to develop bladder cancer than women — possibly because of higher rates of smoking and occupational chemical exposure historically. However, when women do develop bladder cancer, it is often diagnosed at a later stage because symptoms are more commonly attributed to other conditions.

5. Family History and Genetics

Family history cannot be ignored. Having a first-degree relative — parent, sibling, or child — with bladder cancer increases your risk. Certain inherited genetic mutations also increase susceptibility.

6. Chronic Urinary Tract Infections and Bladder Stones

Long-standing, recurrent urinary tract infections and bladder stones cause chronic irritation of the bladder lining, which over time can promote cancer development — particularly squamous cell carcinoma.

7. Previous Cancer Treatment

Patients who have previously received radiation therapy to the pelvis for other cancers — such as cervical or prostate cancer — have a higher risk of developing bladder cancer. Certain chemotherapy drugs — particularly cyclophosphamide — also increase the risk.

8. Chronic Catheter Use

Long-term use of a urinary catheter causes ongoing mechanical irritation of the bladder lining and increases the risk of squamous cell carcinoma of the bladder.

9. Arsenic in Drinking Water

In areas where drinking water contains high levels of arsenic — including parts of India — the risk of bladder cancer is elevated.

Stages of Bladder Cancer

Staging tells your doctor how far the cancer has grown and whether it has spread. This determines the most appropriate treatment.

Stage 0 (Ta and Tis)

Stage 0a (Ta): Non-invasive papillary carcinoma — a small, wart-like tumour growing on the inner surface of the bladder only. Has not invaded the bladder wall. Highly curable.

Stage 0is (Tis / CIS — Carcinoma in Situ): A flat, high-grade tumour confined to the inner lining. Despite being non-invasive, CIS is considered high-risk because of its tendency to progress to muscle-invasive disease. Requires aggressive surveillance.

Stage 1 (T1)

Cancer has grown through the inner lining into the connective tissue layer beneath — but has not reached the muscle wall. Still considered non-muscle-invasive. Five-year survival rate: approximately 88%.

Stage 2 (T2)

Cancer has grown into the muscle wall of the bladder. Now muscle-invasive — a significantly more serious situation.

• T2a: Inner half of the muscle layer
• T2b: Outer half of the muscle layer Five-year survival rate: approximately 63 to 70%.

Stage 3 (T3 and T4a)

Stage 3a (T3): Cancer has grown through the muscle into the fatty tissue surrounding the bladder. Stage 3b (T4a): Cancer has spread to nearby organs — the prostate in men, or the uterus or vagina in women. Five-year survival rate: approximately 35 to 46%.

Stage 4 (T4b and M1)

Stage 4a: Cancer has spread to the pelvic or abdominal wall, or to nearby lymph nodes. Stage 4b (Metastatic): Cancer has spread to distant lymph nodes or organs — most commonly the lungs, liver, and bones. Five-year survival rate: approximately 15%.

How Is Bladder Cancer Diagnosed?

Diagnosing bladder cancer starts with understanding its type and stage, which helps in creating the best treatment plan. Doctors rely on patient history, physical exams, and advanced tests to confirm bladder cancer.

1. Urine Tests

Urinalysis and urine cytology are used to detect abnormal cells, blood, or infection in the urine, which may indicate bladder cancer.

Urinalysis: A basic urine test that can detect blood (haematuria), protein, and signs of infection.

Urine Cytology: A microscopic examination of cells shed into the urine. Abnormal or cancerous cells may be visible. Urine cytology is especially useful for detecting high-grade bladder cancers.

Urine Tumour Markers: Tests like NMP22, BTA stat, and FISH (Fluorescence In Situ Hybridisation) can detect bladder cancer-related molecular markers in the urine. These are sometimes used alongside cytology.

2. Imaging Tests

Tests such as ultrasound, CT scans, and MRI scans provide detailed images of the bladder and surrounding structures.

Ultrasound: A non-invasive first-line imaging test that can detect bladder tumours visible as filling defects in the bladder wall.

CT Urogram (CTU): A specialised CT scan that evaluates the entire urinary tract — kidneys, ureters, and bladder — with contrast dye. It is the gold standard imaging for bladder cancer evaluation and staging.

MRI of the Pelvis: Provides detailed soft tissue images to assess how deeply cancer has invaded the bladder wall — critical for treatment planning.

Chest X-ray / CT Chest: To check whether cancer has spread to the lungs.

Bone Scan: To check for bone metastases in advanced disease.

3. Cystoscopy — The Most Important Diagnostic Tool

Cystoscopy is the definitive method for diagnosing bladder cancer. A thin, flexible tube with a camera — called a cystoscope — is passed through the urethra into the bladder. This allows the urologist or oncologist to directly visualise the inside of the bladder, identify any tumours, and take biopsies.

Flexible cystoscopy uses a flexible scope and is done under local anaesthetic in the clinic. It is used for initial evaluation and surveillance.

Rigid cystoscopy uses a rigid scope under general or spinal anaesthetic — usually combined with TURBT (see below) in the operating theatre.

Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD/Blue Light Cystoscopy): Advanced cystoscopy techniques that use special light to make flat tumours and CIS more visible — improving detection rates significantly compared to standard white light cystoscopy.

4. TURBT — Transurethral Resection of Bladder Tumour

TURBT is both a diagnostic and a therapeutic procedure. Under general or spinal anaesthesia, a cystoscope with a resecting loop is passed into the bladder and the tumour is cut away. The removed tissue is sent for pathological analysis — this is the definitive histological diagnosis of bladder cancer, and the specimen tells the pathologist the tumour type, grade, and depth of invasion.

TURBT is also the primary treatment for non-muscle-invasive bladder cancer.

5. Biopsy and Pathological Analysis

The tissue removed during TURBT is examined by a pathologist who determines:

• The cell type (urothelial, squamous, adenocarcinoma)
• The tumour grade (low grade — slow growing, or high grade — aggressive)
• The depth of invasion (stage T)
• Whether the surgical margins are clear

This information directly guides the treatment plan.

Bladder Cancer Treatment Options

The treatment of bladder cancer depends on the type, grade, and stage of the cancer — as well as the patient’s overall health and preferences. Most patients are managed by a multidisciplinary team including a urologist, urological oncologist, medical oncologist, and radiation oncologist.

1. TURBT (Transurethral Resection of Bladder Tumour)

As described above, TURBT is the primary treatment for all non-muscle-invasive bladder cancers. The tumour is removed through the urethra — no external incision is required. For low-grade NMIBC, TURBT alone may be curative. For high-grade NMIBC, it is followed by intravesical therapy.

2. Intravesical Therapy

For non-muscle-invasive bladder cancer, drugs are instilled directly into the bladder through a catheter — where they act locally on the bladder lining.

Intravesical Chemotherapy: Usually Mitomycin C, instilled into the bladder immediately after TURBT or as a course of treatments. Reduces the risk of cancer recurrence.

BCG (Bacillus Calmette-Guérin) Immunotherapy: BCG is a weakened form of the tuberculosis bacterium that is instilled into the bladder. It stimulates the immune system to attack cancer cells. BCG is the most effective treatment for high-grade NMIBC and CIS — significantly reducing the risk of both recurrence and progression to muscle-invasive disease. It is given in weekly instillations for 6 weeks, followed by maintenance courses.

3. Radical Cystectomy (Bladder Removal)

For muscle-invasive bladder cancer, the standard surgical treatment is radical cystectomy — complete removal of the bladder, along with surrounding lymph nodes and adjacent structures.

In men, this typically includes the prostate and seminal vesicles. In women, it includes the uterus, ovaries, and part of the vaginal wall.

After the bladder is removed, a new way of storing and passing urine must be created — called urinary diversion. The main options are:

Ileal Conduit (urostomy): A segment of bowel is used to create a tube that brings urine from the ureters to a stoma on the abdominal wall, where it drains into an external bag.

Neobladder (orthotopic bladder reconstruction): A new bladder reservoir is constructed from bowel and connected to the urethra — allowing the patient to urinate almost normally without an external bag. This is the preferred option for eligible patients.

Continent cutaneous diversion: A pouch is created internally and accessed through a small stoma using a catheter — no external bag.

Robotic Radical Cystectomy: The cystectomy is increasingly performed using the Da Vinci robotic surgical system — allowing the surgery to be done through tiny incisions with greater precision, less blood loss, and faster recovery. Bangalore’s top hospitals including Apollo and HCG offer robotic cystectomy.

4. Partial Cystectomy

In selected cases — where the tumour is in a specific location and the patient is not suitable for radical cystectomy — part of the bladder can be removed. This is relatively uncommon but can preserve bladder function.

5. Bladder-Sparing Trimodal Therapy (TMT)

For selected patients with muscle-invasive bladder cancer who cannot or prefer not to have their bladder removed, a combination of TURBT, chemotherapy, and radiation therapy can be used — called trimodal therapy or bladder-preservation protocol. It achieves comparable long-term survival to cystectomy in carefully selected patients.

6. Chemotherapy

Neoadjuvant chemotherapy (before surgery): Platinum-based chemotherapy — usually MVAC (Methotrexate, Vinblastine, Doxorubicin, Cisplatin) or GC (Gemcitabine + Cisplatin) — given before radical cystectomy has been shown to improve survival outcomes and is now considered standard of care for muscle-invasive bladder cancer.

Adjuvant chemotherapy (after surgery): Given in high-risk patients to reduce recurrence.

Palliative chemotherapy: For metastatic bladder cancer, platinum-based chemotherapy is the first-line systemic treatment.

7. Immunotherapy

Immune checkpoint inhibitors have revolutionised the treatment of advanced bladder cancer in recent years.

Pembrolizumab (Keytruda) and Atezolizumab are approved for bladder cancer patients whose disease has progressed after platinum-based chemotherapy — or as first-line therapy in patients who are not suitable for cisplatin. These drugs block the PD-1/PD-L1 pathway, allowing the immune system to recognise and destroy cancer cells.

Erdafitinib (Balversa) — a targeted therapy for patients whose tumours have FGFR3 or FGFR2 gene alterations — is another important advance in bladder cancer treatment.

Enfortumab Vedotin — an antibody-drug conjugate — has shown remarkable results in advanced bladder cancer and is increasingly available at India’s top cancer centres.

8. Radiation Therapy

Radiation therapy uses high-energy X-rays to destroy cancer cells. In bladder cancer it is used:

• As part of trimodal therapy (bladder-preservation approach)
• For palliative treatment — to control bleeding, pain, or other symptoms in advanced disease
• To treat metastases in specific locations

Advanced radiation techniques like IMRT (Intensity Modulated Radiation Therapy) and image-guided radiation therapy allow precise targeting of the tumour while minimising damage to the surrounding bladder wall and nearby organs.

Bladder Cancer Surveillance — The Importance of Follow-Up

Bladder cancer has one of the highest recurrence rates of any cancer — up to 70% of non-muscle-invasive cases recur within 5 years. This makes lifelong surveillance absolutely essential.

After treatment, patients undergo regular cystoscopies — every 3 months for the first year, every 6 months for the second year, and annually thereafter — to check for recurrence. Urine cytology and CT urograms are also performed at regular intervals.

This intensive follow-up schedule is not optional — it is a critical part of bladder cancer management and one of the most important things a bladder cancer patient can do for their long-term survival.

Bladder Cancer Treatment Cost in India

India offers world-class bladder cancer treatment at a fraction of what it costs in Western countries:

Compare this to the US where radical cystectomy alone costs ₹30 to 60 lakh and immunotherapy cycles cost ₹8 to 15 lakh each. India offers the same quality of care at 80 to 90% lower cost.

Best Hospitals for Bladder Cancer Treatment in Bangalore

HCG Cancer Hospitals Bangalore — India’s largest dedicated cancer network specialises exclusively in oncology. Their uro-oncology department handles bladder cancer comprehensively — from TURBT and BCG therapy through to robotic radical cystectomy and immunotherapy.

Apollo Hospitals Bangalore — Has a comprehensive uro-oncology programme with experienced urological surgeons and oncologists. Offers robotic cystectomy using the Da Vinci system and all systemic treatment options including immunotherapy.

Aster CMI Hospital Bangalore — Ranked #1 in Bangalore, Aster CMI has experienced uro-oncologists and a multidisciplinary tumour board approach to bladder cancer management.

Fortis Hospital Bangalore — Strong urology and oncology departments with experienced surgeons handling bladder cancer surgery and a comprehensive medical oncology team for systemic treatments.

Manipal Hospitals Bangalore — Offers bladder cancer surgery, chemotherapy, and immunotherapy with experienced oncology teams across multiple locations.

How Doctor Visit Bangalore Can Help

Whether you are in Bangalore, another city in India, or coming from abroad — Doctor Visit Bangalore connects you with the right uro-oncologist or urological surgeon for bladder cancer treatment quickly and easily.

We help with:

• Free specialist recommendation and appointment booking
• Understanding your biopsy and imaging reports
• Getting a second opinion before committing to treatment
• Transparent cost estimate within 24 hours
• Medical visa assistance for international patients
• Airport pickup and accommodation near the hospital
• Complete treatment coordination through TURBT, BCG, surgery, chemo, and immunotherapy
• Post-treatment surveillance appointment coordination

Our service is completely free. Contact us today.

📞 Call Now: +91 78920 28951 💬 WhatsApp: +91 78920 28951 📧 Info@doctorvisitbangalore.com 🌐 www.doctorvisitbangalore.com

Frequently Asked Questions About Bladder Cancer

What is bladder cancer? Bladder cancer is a cancer that begins in the cells lining the bladder — most commonly the urothelial cells. It is the most common urinary tract cancer and accounts for 3% of all cancer cases in India. It affects men more commonly than women.

What is the most common symptom of bladder cancer? Blood in the urine — called haematuria — is the most common and most important symptom of bladder cancer. It may be visible (pink, red, or brown urine) or detectable only through a urine test. It often comes and goes, which leads many people to ignore it. Any blood in urine should be investigated by a doctor immediately.

Is bladder cancer curable? Early-stage non-muscle-invasive bladder cancer is highly curable — with five-year survival rates of 88% or higher for Stage 1 disease. Muscle-invasive bladder cancer is more serious but can still be treated successfully, particularly when caught at Stage 2. Advanced metastatic bladder cancer is not currently curable but modern immunotherapy and targeted therapies have significantly improved survival.

What causes bladder cancer? Smoking is the single biggest cause — smokers are 2 to 3 times more likely to develop bladder cancer. Other causes include occupational exposure to industrial chemicals, chronic urinary tract infections, age, family history, previous cancer treatment with radiation or cyclophosphamide, and arsenic in drinking water.

How is bladder cancer diagnosed? Diagnosis involves urine tests (urinalysis and cytology), imaging (CT urogram, ultrasound, MRI), and cystoscopy — a camera examination of the inside of the bladder. The definitive diagnosis is made through TURBT — where the tumour is removed and sent for pathological analysis.

What is TURBT? TURBT stands for Transurethral Resection of Bladder Tumour. It is a procedure where a cystoscope is passed through the urethra into the bladder and the tumour is cut away using an electric loop. It is both a diagnostic procedure (providing tissue for pathology) and the primary treatment for non-muscle-invasive bladder cancer.

What is BCG therapy for bladder cancer? BCG (Bacillus Calmette-Guérin) is a weakened form of the tuberculosis bacterium that is instilled directly into the bladder through a catheter. It stimulates the immune system to attack cancer cells and is the most effective treatment for high-grade non-muscle-invasive bladder cancer, significantly reducing the risk of recurrence and progression.

Do I have to have my bladder removed? Not necessarily. Only muscle-invasive bladder cancer typically requires bladder removal (radical cystectomy). Most bladder cancers — approximately 75% at diagnosis — are non-muscle-invasive and can be treated with TURBT and BCG without removing the bladder. Even some muscle-invasive cases can be treated with bladder-preservation trimodal therapy (TURBT + chemotherapy + radiation) in selected patients.

What happens after the bladder is removed? After radical cystectomy, a urinary diversion is created. Options include an ileal conduit (urostomy with an external bag), a neobladder (a new bladder made from bowel that allows normal urination), or a continent cutaneous diversion (an internal pouch accessed by catheter). Your surgeon will discuss the most appropriate option based on your anatomy and preferences.

How often does bladder cancer recur? Bladder cancer has one of the highest recurrence rates of any cancer — up to 70% of non-muscle-invasive cases recur within 5 years. This is why regular cystoscopy surveillance after treatment is absolutely essential. Recurrences are usually detected early during surveillance and can be treated effectively.

Can bladder cancer be prevented? Not completely, but the risk can be significantly reduced by stopping smoking (the most important step), avoiding occupational chemical exposure, staying well hydrated (which dilutes carcinogens in the urine), and treating urinary tract infections promptly.

What is the difference between bladder cancer and kidney cancer? Both affect the urinary system but are distinct diseases. Bladder cancer begins in the bladder lining — most often causing blood in urine and urinary symptoms. Kidney cancer begins in the kidney tissue — often causing flank pain, a palpable mass, or blood in urine. They require different surgical and systemic treatments. If you have urinary symptoms, a CT urogram evaluates both the kidneys and the bladder.

Is bladder cancer treatment available in India for international patients? Yes — India’s top cancer hospitals offer world-class bladder cancer treatment at 80 to 90% lower cost than Western countries. Doctor Visit Bangalore helps international patients from Africa, the Middle East, and Europe access the right uro-oncologist, arrange treatment, and coordinate their full journey including medical visa, accommodation, and follow-up.

What is the cost of bladder cancer treatment in India? TURBT costs approximately ₹50,000 to ₹1,50,000. Radical cystectomy costs ₹2,00,000 to ₹4,00,000 for open surgery or ₹3,50,000 to ₹6,00,000 for robotic surgery. Chemotherapy costs ₹30,000 to ₹1,50,000 per cycle and immunotherapy ₹1,50,000 to ₹4,00,000 per cycle. Contact Doctor Visit Bangalore for a personalised estimate based on your diagnosis and stage.

Do Not Wait — Blood in Urine Is Never Normal

Bladder cancer whispers before it screams. Blood in your urine — even once, even painless, even if it disappears — is your body’s warning signal that something needs to be investigated.

The patients who do best with bladder cancer are those who acted on that first warning. Who did not dismiss it as a UTI. Who went to a doctor, had a cystoscopy, and found out early.

If you have any symptoms described in this guide — or if you have risk factors like a long history of smoking, occupational chemical exposure, or recurrent UTIs — please do not wait. Contact Doctor Visit Bangalore today. We will connect you with the right uro-oncologist in Bangalore within 24 hours.

Your bladder is trying to tell you something. Listen to it.

📞 +91 78920 28951 💬 WhatsApp Now 🌐 doctorvisitbangalore.com